Bioassay of dixathion for possible carcinogenicity / Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
Published:
Bethesda, Md. : U. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1978.
Title from title screen (viewed on Oct. 11, 2012). "CAS no. 78-34-2." "NCI-CG-TR-125." Conducted for the Carcinogenesis Testing Program, National Cancer Institute, by Hazleton Laboratories America, inc., Vienna, Va.